This announcement is a separate document:
サンバイオ：「米国における慢性虚血性脳卒中に対するSB623を用いた細胞療法の新規特許の許可に関する通知」の一部改訂
SanBio: Partial Revision of the Notice on the Grant of a Novel Patent for Cell Therapy Using SB623 for Chronic Ischemic Stroke in the United States.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.